This study demonstrates that most ERG-overexpressing prostate cancers harbor hormonally regulated TMPRSS2-ERG, SLC45A3-ERG, or NDRG1-ERG fusions.     ///    "Screening for known 5' partners, we determined that three cases harbored the SLC45A3-ERG fusion. "